Navigation Links
LSUHSC awarded $2 million dollar grant to prevent pneumonia linked to immune deficiency
Date:7/13/2010

New Orleans, LA Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to determine the role and identify which T-helper cells fight the opportunistic infection, Pneumocystis carinii pneumonia (PCP), which can be a complication of HIV/AIDS. It can also be a complication of cancer, organ or bone marrow transplantation, as well as the chronic use of corticosteroids or other medications that affect the immune system.

Pneumocystis carinii pneumonia remains an important clinical problem and although there is a well-known relationship between CD4 cell count and the risk of Pneumocystis carinii infection, defense mechanisms against it are not fully understood. Dr. Kolls and his research team will study the role of a subset of CD4 cells which he believes are missing in Pneumocystis carinii infection and which when restored, produce an effective immune response to the infection. These are the T-helper cells, Th1, Th2, and Th17. The research funded under this grant will determine the role of interleukin-23 and interleukin-12 in regulating Th1 immunity to Pneumocystis carinii, and the team hopes to show that by vaccinating genetically engineered mice with CD4+ T-cells belonging to any of these T-cell subsets, immunity will be sufficient to protect against PCP.

"This research will define the types of T-cells that are needed to prevent this life-threatening infection," notes Dr. Kolls. "It is our hope that vaccines can activate these cells to prevent or treat PCP."

According to the Centers for Disease Control and Prevention, Pneumocystis pneumonia (PCP), which is caused by Pneumocystis jirovecii (formerly P. carinii), is frequently the first serious illness encountered by HIV-infected persons. During the ea
'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. LSUHSC awarded patent for compound inhibiting cancer and other diseases
2. LSUHSC research identifies key contributor to Alzheimers disease process
3. LSUHSC student awarded top national honor for diabetes research
4. LSUHSC public health researcher finds reason for weight gain
5. LSUHSC research describes function of key protein in cancer spread
6. LSUHSCs Kolls awarded $1.8 million to improve vaccine strategies for P. carinii pneumonia
7. LSUHSC research helps link schizophrenia to specific DNA region
8. LSUHSCs Bazan awarded ARRA grant to preserve vision
9. LSUHSC shows for first time infant inhalation of ultrafine air pollution linked to adult lung disease
10. Grant supports LSUHSC research on how like cell receptor systems determine very different functions
11. LSUHSC researchers working to prevent diabetic neuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2014)... paper from a team of Florida State University biologists ... could adapt to and survive environmental swings such as ... latest issue of the journal The Plant Cell ... DNA and proteins) is organized in a cell and ... are turned on and others are turned off. , ...
(Date:11/5/2014)... Santamaria, associate professor of biology in the UTSA ... in the nation selected to receive a two-year ... for Exploratory Research (EAGER). The funding supports President ... researchers to create new technology that will demystify ... complex behaviors in neuroscience are broken into the ...
(Date:11/4/2014)... the right amount of death at the right time ... to new research that could help in understanding animal ... , In a paper in the journal Trends ... and European colleagues conclude that the kind of positive ... of individuals, or mortality, depends on the size and ...
Breaking Biology News(10 mins):Maize analysis yields whole new world of genetic science 2UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3When less is more: Death in moderation boosts population density in nature 2
... identified a gene that drives the development of tumours in ... the first time that the gene CUX1 has been broadly ... CUX1 is deactivated, a biological pathway is activated that increases ... being used in the clinic and are in development thus ...
... According to Gertrude Stein, "A rose is a rose ... be the case when it comes to the rose,s scent. ... that as much as 30 percent of the large array ... substantial variation is in turn reflected by variability in how ...
... eye following even a mild traumatic brain injury. While the ... Nature suggest that the brain,s protective coverings may ... newly developed mouse trauma model, senior author Dorian McGavern, Ph.D., ... (NINDS), part of the National Institutes of Health, watched specific ...
Cached Biology News:Gene promotes 1 in 100 of tumors 2Extensive variability in olfactory receptors influences human odor perception 2Concussion secrets unveiled in mice and people 2Concussion secrets unveiled in mice and people 3
(Date:11/28/2014)... The American Association of Colleges ... of Nursing with a very prestigious award for ... 2014 Innovations in Professional Nursing Education Award recognizes ... supports them as they re-envision traditional models for ... annual meeting in Washington, D.C. to Meredith Wallace ...
(Date:11/27/2014)... Nov. 27, 2014 Research and ... "Global Palmitic Acid Industry Report 2014" report to ... The Global Palmitic Acid Industry Report 2014 ... state of the global palmitic acid industry. ... including definitions, classifications, applications and industry chain structure. The ...
(Date:11/27/2014)... , November 27, 2014 ... revolutionising the management of tooth decay, today announces ... of its Calcivis® Caries Activity Imaging System. ... a sophisticated medical device and consumable combination designed ... caries (tooth decay). It involves a unique, proprietary ...
(Date:11/26/2014)... The report on the Global Smart ... concerned market for revenue forecasts and market trends. It ... 51.9% from 2013 to 2018. At the projected rate, ... $1,415.6 million by 2018. , Browse through the Global ... information about the market segmentation and in-depth analysis supported ...
Breaking Biology Technology:American Association of Colleges of Nursing honors Fairfield University’s School of Nursing for Re-envisioning Nursing Education 2Global Palmitic Acid Industry Report 2014 2Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 2Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 2Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 4
... FRANCISCO, July 8 Nile Therapeutics, Inc. (Nasdaq: ... therapeutics for heart failure patients, today announced that it has ... securities of the Company for aggregate gross proceeds of approximately ... acted as the exclusive placement agent for the transaction. , ...
... CAMBRIDGE, England, July 8 Funxional Therapeutics ... first Phase,I study with FX125L, an orally available small ... Spectrum Chemokine Inhibitors (BSCIs). , ... in the United,States. FX125L was well tolerated at all ...
... CHENGDU, China, July 8 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical ... and supplier of,modernized traditional Chinese medicine ("TCM") based in Chengdu, ... its common stock shareholders.,The dividend of $0.025 will be paid ... actual distribution occurring on or about September 10, 2009. , ...
Cached Biology Technology:Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement 2Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement 3Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement 4Funxional Successfully Completes Initial Clinical Trial of FX125L, an Anti-Inflammatory Drug With a Novel Mechanism of Action 2Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders 2
... T antigen initiates replication from ... in the presence of the ... can be used in conjunction ... Kit cat. no. 8050. ...
Raised to 5-HIAA coupled to BSA with paraformaldehyde....
Request Info...
NuCycl DAPI Kit Application: Flow Cytometry Reactivity: Human...
Biology Products: